Related Experiment Video
Updated: Sep 19, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Diagnostic value of novel thrombus markers in COPD with deep venous thrombosis
Jiajun Huang1, Jie Huang2, Chunli Sun2
1School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, Guangdong, PR China.
Insights
New thrombosis markers like thrombin antithrombin complex (TAT) and thrombomodulin (TM) show diagnostic value for predicting deep venous thrombosis (DVT) in chronic obstructive pulmonary disease (COPD) patients.
Area of Science:
- Cardiology
- Pulmonology
- Hematology
Background:
- Chronic obstructive pulmonary disease (COPD) patients are at increased risk for deep venous thrombosis (DVT).
- Accurate diagnostic markers for DVT in COPD are crucial for timely intervention.
- Traditional markers may not fully capture the thrombotic risk in this population.
Purpose of the Study:
- To evaluate the diagnostic utility of novel thrombosis markers for DVT incidence in COPD patients.
- To compare the efficacy of thrombin antithrombin complex (TAT), plasmin-α2-plasmin inhibitor complex (PIC), thrombomodulin (TM), and tissue plasminogen activator-inhibitor complex (t-PAIC).
Main Methods:
- A cohort of 98 COPD patients and 50 healthy controls were analyzed.
- Patients were categorized into non-DVT and DVT groups.
- Blood glucose, lipid profiles, and novel thrombosis markers were measured; ROC curve analysis was employed.
Main Results:
- No significant differences in glucose or lipid profiles were observed between groups.
- Fibrin degradation product (FDP) and D-dimer (D-D) were elevated in the DVT group.
- TAT, PIC, TM, and t-PAIC levels were significantly higher in COPD patients with DVT. Combined TAT and TM showed high diagnostic efficacy (AUC 0.833, sensitivity 87.5%).
Conclusions:
- Serum levels of TAT, PIC, TM, and t-PAIC are valuable diagnostic indicators for DVT in COPD patients.
- The combination of TAT and TM offers superior diagnostic performance.
- These markers can aid in the early detection and management of DVT in this high-risk group.
Background:
This study assesses the diagnostic value of new thrombosis markers, including thrombin antithrombin complex (TAT), plasmin-α2-plasmin inhibitor complex (PIC), thrombomodulin (TM), and tissue plasminogen activator-inhibitor complex (t-PAIC), for the incidence prediction of deep venous thrombosis (DVT) of lower limb in chronic obstructive pulmonary disease (COPD) patients.
Methods:
98 patients with COPD admitted to Shenzhen Guangming district people's hospital from March 2020 to May 2022 and were selected and divided into a non-DVT group (n = 62) and a DVT (n = 36) group. A control group consisting of 50 healthy subjects were recruited. The blood sugar and lipid metabolic indicators of patients in each group were analyzed and compared. ROC curve analysis was performed to assess the diagnostic efficacy of new thrombosis markers.
Results:
There were no significant differences in the levels of fasting blood glucose (FBG), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) among the three groups. The DVT group exhibited higher levels of fibrin degradation product (FDP) and D-dimer (D-D) than the non-DVT group. The plasma levels of TAT, PIC, TM, and t-PAIC in the DVT group significantly elevated compared to the other two groups. Combined diagnosis of TAT and TM displayed superior diagnostic efficacy with maximum AUC values (0.833) and a sensitivity of 87.5 %.
Conclusions:
The detection of serum levels of TAT, PIC, TM, and t-PAIC have diagnostic value in COPD patients with DVT.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Venous Thrombosis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

